CoChat

A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis

Open access

Published version of a preprint

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Calcific aortic valve stenosis (CAVS) is a common and life-threatening heart disease and the current treatment options cannot stop or delay its progression. A GWAS on 1009 cases and 1017 ethnically matched controls was combined with a large-scale eQTL mapping study of human aortic valve tissues ( n = 233) to identify susceptibility genes for CAVS. Replication was performed in the UK Biobank, including 1391 cases and 352,195 controls. A transcriptome-wide association study (TWAS) reveals PALMD (palmdelphin) as significantly associated with CAVS. The CAVS risk alleles and increasing disease severity are both associated with decreased mRNA expression levels of PALMD in valve tissues. The top variant identified shows a similar effect and strong association with CAVS ( P = 1.53 × 10 −10 ) in UK Biobank. The identification of PALMD as a susceptibility gene for CAVS provides insights into the genetic nature of this disease, opens avenues to investigate its etiology and to develop much-needed therapeutic options.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-03260-6

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Manhattan plots showing the GWAS in QUEBEC-CAVS and TWAS results. a Genetic associations with CAVS observed in 1009 cases and 1017 controls. The y-axis represents P value in −log10 scale. The horizontal blue line indicates a P value of 1 × 10−5. The magenta dot indicates rs6702619. b Transcriptome-wide association in valve tissue with CAVS. P values for gene expression-CAVS associations are on the y-axis in −log10 scale. The blue horizontal line represents PTWAS of 0.05. The magenta horizontal line represents the genome-wide significant threshold used in this study (PTWAS < 0.0001). Annotations for the top significant probes are indicated
Fig. 1 Manhattan plots showing the GWAS in QUEBEC-CAVS and TWAS results. a Genetic associations with CAVS observed in 1009 cases and 1017 controls. The y-axis represents P value in −log10 scale. The horizontal blue line indicates a P value of 1 × 10−5. The magenta dot indicates rs6702619. b Transcriptome-wide association in valve tissue with CAVS. P values for gene expression-CAVS associations are on the y-axis in −log10 scale. The blue horizontal line represents PTWAS of 0.05. The magenta horizontal line represents the genome-wide significant threshold used in this study (PTWAS < 0.0001). Annotations for the top significant probes are indicatedCC BY · PubMed Central
Fig. 2 PALMD is the candidate causal gene on the 1p21.2 CAVS susceptibility locus. a GWAS and valve eQTL results surrounding PALMD on chromosome 1p21. The upper panel shows the genetic associations with CAVS. The bottom panel shows the valve eQTL statistics for the PALMD gene. The extent of linkage disequilibrium (LD; r2 values) for all SNPs with rs6702619 is indicated by colors. The location of genes in this locus is illustrated at the bottom. b PALMD gene expression levels in aortic valves by genotyping groups for SNP rs6702619. The y-axis shows PALMD mRNA expression levels. The x-axis denotes the three genotype groups. The number of individuals is indicated in parentheses. The CAVS risk allele is illustrated in red. Boxplot boundaries represent the first and third quartiles, whiskers are the most extreme data point, which is no more than 1.5 times the interquartile range, and the center mark represents the median. The black bar and the right y-axis indicate the variance in PALMD gene expression explained by rs6702619. c Scatterplot of the 1p21.2 susceptibility locus showing SNP associations with CAVS and PALMD gene expression in aortic valve tissues. The y-axis represents variant association with CAVS (Z score). The x-axis shows association with PALMD gene expression (t statistic). Variants are colored based on the degree of LD (r2) with the top CAVS-associated variant rs6702619. The blue line is the regression slope with 95% confidence interval (red lines)
Fig. 2 PALMD is the candidate causal gene on the 1p21.2 CAVS susceptibility locus. a GWAS and valve eQTL results surrounding PALMD on chromosome 1p21. The upper panel shows the genetic associations with CAVS. The bottom panel shows the valve eQTL statistics for the PALMD gene. The extent of linkage disequilibrium (LD; r2 values) for all SNPs with rs6702619 is indicated by colors. The location of genes in this locus is illustrated at the bottom. b PALMD gene expression levels in aortic valves by genotyping groups for SNP rs6702619. The y-axis shows PALMD mRNA expression levels. The x-axis denotes the three genotype groups. The number of individuals is indicated in parentheses. The CAVS risk allele is illustrated in red. Boxplot boundaries represent the first and third quartiles, whiskers are the most extreme data point, which is no more than 1.5 times the interquartile range, and the center mark represents the median. The black bar and the right y-axis indicate the variance in PALMD gene expression explained by rs6702619. c Scatterplot of the 1p21.2 susceptibility locus showing SNP associations with CAVS and PALMD gene expression in aortic valve tissues. The y-axis represents variant association with CAVS (Z score). The x-axis shows association with PALMD gene expression (t statistic). Variants are colored based on the degree of LD (r2) with the top CAVS-associated variant rs6702619. The blue line is the regression slope with 95% confidence interval (red lines)CC BY · PubMed Central
Fig. 3 Mendelian randomization analysis of the association between PALMD gene expression and CAVS risk. Each circle represents 1 of 12 SNPs located within 200 kb of PALMD selected for association with PALMD gene expression (P < 0.05) using stepwise regression. The blue line is the regression slope using the Wald method. The magenta dashed lines represent 95% confidence intervals from bootstrap. a Effect on CAVS risk from QUEBEC-CAVS cohort against effect on PALMD gene expression (P = 0.0036). b Effect on CAVS risk from UK Biobank against effect on PALMD gene expression (P = 1.18 × 10−5)
Fig. 3 Mendelian randomization analysis of the association between PALMD gene expression and CAVS risk. Each circle represents 1 of 12 SNPs located within 200 kb of PALMD selected for association with PALMD gene expression (P < 0.05) using stepwise regression. The blue line is the regression slope using the Wald method. The magenta dashed lines represent 95% confidence intervals from bootstrap. a Effect on CAVS risk from QUEBEC-CAVS cohort against effect on PALMD gene expression (P = 0.0036). b Effect on CAVS risk from UK Biobank against effect on PALMD gene expression (P = 1.18 × 10−5)CC BY · PubMed Central
Fig. 4 Relationship between PALMD expression levels and CAVS severity. PALMD-normalized, age- and sex-adjusted mRNA expression levels in 239 aortic valve tissues according to CAVS disease severity assessed by a aortic valve area (P = 0.0027), b mean (P = 0.0001), and c peak transvalvular gradients (P = 8.13 × 10−5). The blue lines represent the slopes obtained by linear regression with 95% confidence interval (magenta lines)
Fig. 4 Relationship between PALMD expression levels and CAVS severity. PALMD-normalized, age- and sex-adjusted mRNA expression levels in 239 aortic valve tissues according to CAVS disease severity assessed by a aortic valve area (P = 0.0027), b mean (P = 0.0001), and c peak transvalvular gradients (P = 8.13 × 10−5). The blue lines represent the slopes obtained by linear regression with 95% confidence interval (magenta lines)CC BY · PubMed Central
Fig. 5 Replication in UK Biobank. a Forest plot of overall effect size for rs6702619 in the discovery (QUEBEC-CAVS) and validation (UK Biobank) cohorts. The blue filled squares represent the odds ratio (OR) for each cohort with 95% confidence intervals illustrated by horizontal lines. The gray vertical line represents an OR of 1.0 and the dashed magenta line is the OR of the meta-analysis. b Manhattan plot showing the GWAS in UK Biobank comparing 1391 CAVS cases and 352,195 controls. The horizontal blue and magenta lines indicate PGWAS values of 1 × 10−5 and 5 × 10−8, respectively. Three SNPs were significant at the PGWAS threshold of 5 × 10−8: rs74617384 and rs10455872 at the LPA locus and rs7543130 (in perfect LD with rs6702619) at the PALMD locus
Fig. 5 Replication in UK Biobank. a Forest plot of overall effect size for rs6702619 in the discovery (QUEBEC-CAVS) and validation (UK Biobank) cohorts. The blue filled squares represent the odds ratio (OR) for each cohort with 95% confidence intervals illustrated by horizontal lines. The gray vertical line represents an OR of 1.0 and the dashed magenta line is the OR of the meta-analysis. b Manhattan plot showing the GWAS in UK Biobank comparing 1391 CAVS cases and 352,195 controls. The horizontal blue and magenta lines indicate PGWAS values of 1 × 10−5 and 5 × 10−8, respectively. Three SNPs were significant at the PGWAS threshold of 5 × 10−8: rs74617384 and rs10455872 at the LPA locus and rs7543130 (in perfect LD with rs6702619) at the PALMD locusCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 135

Metadata

Authors
Thériault, S., Gaudreault, N., Lamontagne, M., Rosa, M., Boulanger, M.-C., Messika-Zeitoun, D., Clavel, M.-A., Capoulade, R., Dagenais, F., Pibarot, P., Mathieu, P., & Bossé, Y.
Affiliations
Institut universitaire de cardiologie et de pneumologie de Québec (CA)
Corresponding author
Bossé, Yohan
Venue
Nature Communications
Published
2018-03-07
Volume
9
Issue
1
Pages
988-988
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2950772595
Cited by
135
References
53
Citations by year
2026: 8 · 2025: 17 · 2024: 20 · 2023: 15 · 2022: 20 · 2021: 20 · 2020: 16 · 2019: 11 · 2018: 6
FWCI
10.01
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Corpus Université Laval (Université Laval) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Heart and Stroke Foundation of Canada
  • Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval
  • Canadian Institutes of Health Research
  • Fonds de Recherche du Québec - Santé
  • Medical Research Council (MC_PC_17228)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
Keywords
calcific aortic stenosis, susceptibility genes, transcriptome-wide association study, expression quantitative trait loci, aortic valve tissue, gene expression, disease severity, genetic risk variants
MeSH terms
Aortic Valve, Aortic Valve Stenosis, Calcinosis, Humans, Membrane Proteins, Disease Progression, Genetic Predisposition to Disease, Genome-Wide Association Study, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis. https://app.cochat.ai/papers/10.1038/s41467-018-03260-6
The paper
Thériault, S., Gaudreault, N., Lamontagne, M., Rosa, M., Boulanger, M.-C., Messika-Zeitoun, D., Clavel, M.-A., Capoulade, R., Dagenais, F., Pibarot, P., Mathieu, P., & Bossé, Y. (2018). A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis. Nature Communications. https://doi.org/10.1038/s41467-018-03260-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.